British American Tobacco p.l.c.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $33.78B | $33.06B | $33.94B | $34.21B | $35.35B | $33.07B | $33.04B |
| Vapour | $2.03B | $2.20B | $2.25B | $1.78B | $1.28B | $783.9M | $512.0M |
| HP | $1.21B | $1.18B | $1.24B | $1.31B | $1.17B | $813.4M | $929.5M |
| Modern Oral | $1.54B | $1.01B | $670.5M | $492.4M | $377.1M | $254.0M | $160.9M |
| Traditional Oral | $1.38B | $1.40B | $1.45B | $1.50B | $1.54B | $1.49B | $1.38B |
| Combustibles | $26.65B | $26.44B | $27.50B | $28.49B | $30.32B | $29.19B | $29.37B |
| Other | $982.8M | $841.0M | $827.3M | $645.8M | $664.8M | $540.1M | $689.5M |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 2.31B | 2.35B | 2.46B | 2.46B | 2.46B | 2.46B | 2.46B |
| Shares Outstanding (Diluted) | 2.31B | 2.35B | 2.46B | 2.46B | 2.46B | 2.46B | 2.46B |
| Dividends Per Share | — | — | — | — | — | — | — |